Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. (ADYX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 5 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on May 3, 2019 involved a transaction of 142,090 shares valued at $0.
ADYX Insider Activity Summary
Who Is Buying ADYX Stock?
No significant insider buying has been recorded for ADYX in the recent period.
Who Is Selling ADYX Stock?
No significant insider selling has been recorded for ADYX in the recent period.
Is Alliqua BioMedical, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ADYX is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
ADYX Frequently Asked Questions
Understanding ADYX Insider Activity
Insider trading at Alliqua BioMedical, Inc. (ADYX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading ADYX stock, having executed 5 transactions in the past 90 days. The most active insider is Rick Orr (Executive), who has made 1 transactions totaling $0.
Related Tools
Track Alliqua BioMedical, Inc. Insider Activity
Get notified when executives and directors at ADYX file new Form 4 transactions